Posaten-Polystyrene Sulfonate Calcium Salt

Posaten-Polystyrene Sulfonate Calcium Salt
Product Description

Polystyrene Sulfonate Calcium Salt is a cation-exchange resin used in the management of hyperkalaemia. It acts in the gastrointestinal tract by exchanging calcium ions for potassium ions, thereby promoting potassium removal through the feces and helping reduce elevated serum potassium levels. The product is available as granules containing 880 mg/g, supplied in sachet packs of 20, 60 and 120 units, providing different pack-size options for ongoing treatment according to local prescribing information.

Ilko Ilac Sanayi ve Ticaret A.S

  • Country/Region:
    Türkiye
  • Founded:
    2012
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
OTC
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Therapeutic Area: Various / Other Therapeutic Products Therapeutic Class: Hyperkalaemia Products 
    Application Areas: Treatment of hyperkalaemia by reducing excess potassium through gastrointestinal ion exchange, subject to the approved local prescribing informatio
  • Model
    Granule Sachet
  • Supplied from
    Türkiye
  • Measured In
    piece

Ilko Ilac Sanayi ve Ticaret A.S

  • Country/Region:
    Türkiye
  • Founded:
    2012
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
OTC
Pharmaceutical Company (generic finished products)

More Products from Ilko Ilac Sanayi ve Ticaret A.S (99)

  • Lunges- Levodropropizine

    Product Lunges- Levodropropizine

    Levodropropizine is a peripherally acting antitussive agent used for the symptomatic treatment of non-productive cough. It helps suppress the cough reflex primarily through a peripheral mechanism, with limited central nervous system involvement compared with centrally acting antitussives. The product is av...
  • Fentus- Levocloperastine Fendizoate

    Product Fentus- Levocloperastine Fendizoate

    Levocloperastine Fendizoate is an antitussive agent used for the symptomatic treatment of non-productive cough. It acts on the cough reflex through both peripheral and central mechanisms, helping reduce cough frequency and intensity. The product is available as an oral suspension containing 708 mg / 100 mL...
  • Griport- Paracetamol / Pseudoephedrine HCl / Chlorpheniramine Maleate

    Product Griport- Paracetamol / Pseudoephedrine HCl / Chlorpheniramine Maleate

    Paracetamol / Pseudoephedrine HCl / Chlorpheniramine Maleate is a fixed-dose combination used for the symptomatic relief of common cold and flu symptoms. Paracetamol provides analgesic and antipyretic activity, pseudoephedrine acts as a nasal decongestant, and chlorpheniramine is an antihistamine that help...
  • Alrinast - Desloratadine

    Product Alrinast - Desloratadine

    Desloratadine is a second-generation antihistamine used for the relief of symptoms associated with allergic conditions. It selectively blocks peripheral histamine H1 receptors, helping reduce symptoms such as sneezing, rhinorrhea, nasal and ocular itching, and urticaria-related itching and wheals. The port...
  • Alerinit- Levocetirizine Dihydrochloride

    Product Alerinit- Levocetirizine Dihydrochloride

    Levocetirizine Dihydrochloride is a second-generation antihistamine used for the symptomatic treatment of allergic conditions. It selectively blocks peripheral histamine H1 receptors, helping relieve symptoms such as sneezing, rhinorrhea, nasal and ocular itching, and urticaria-related itching and wheals. ...
  • Ruftan- Rupatadine Fumarate

    Product Ruftan- Rupatadine Fumarate

    Rupatadine Fumarate is a second-generation antihistamine used for the symptomatic treatment of allergic conditions. It acts as a selective peripheral histamine H1-receptor antagonist and also exhibits platelet-activating factor (PAF) antagonist activity, helping control multiple mediators involved in aller...
  • Enferox- Deferasirox

    Product Enferox- Deferasirox

    Deferasirox is an oral iron-chelating agent used for the management of chronic iron overload. It binds excess iron with high affinity and facilitates its elimination, primarily through the feces, helping reduce iron accumulation associated with repeated blood transfusions or other conditions causing iron o...
  • Dasatinib

    Product Dasatinib

    Dasatinib is an oral tyrosine kinase inhibitor targeting BCR-ABL and other relevant kinases involved in malignant cell proliferation. It is available as 20 mg, 50 mg and 70 mg film-coated tablets in packs of 60, and as 100 mg and 140 mg film-coated tablets in packs of 30. The broad strength range supports ...
  • Erlotinib

    Product Erlotinib

    Erlotinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor that helps inhibit signalling pathways associated with tumour-cell proliferation and survival. It is available as 100 mg and 150 mg tablets in packs of 30, providing strength options for standard treatment and dose adjustment r...
  • Sunitinib

    Product Sunitinib

    Sunitinib is an oral antineoplastic agent used in the treatment of selected solid tumors. It is a multi-targeted tyrosine kinase inhibitor that blocks several receptor tyrosine kinases involved in tumor cell proliferation, angiogenesis and disease progression. The product is available in 12.5 mg, 25 mg and...
  • Ruxolitinib

    Product Ruxolitinib

    Ruxolitinib is an oral Janus kinase 1 and 2 inhibitor developed to modulate abnormal JAK-STAT signalling associated with selected haematological disorders. It is available as 5 mg, 10 mg, 15 mg and 20 mg tablets in multiple pack sizes, including 14, 56 and 168 tablets depending on the strength, supporting ...
  • Sorafenib

    Product Sorafenib

    Sorafenib is an oral multikinase inhibitor targeting signalling pathways involved in tumour-cell proliferation and tumour angiogenesis. It is available as 200 mg film-coated tablets in packs of 112, designed to support the established dosing schedule used in eligible oncology patients.  Expected ...

Ilko Ilac Sanayi ve Ticaret A.S resources (2)